Announcement under Regulation 30 (LODR) - Communication sent to shareholders relating to notice of transfer to IEPF

July 29, 2026 BSE Limited National Stock Exchange of India Limited Floor 25, P. J. Towers Exchange Plaza Dalal Street, Fort Bandra Kurla Complex, Bandra (E) Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 530019 Symbol: JUBLPHARMA Dear Sir, Madam, Sub: Submission of communication sent to shareholders relating to notice of transfer of equity shares / dividend to Investor Education and Protection Fund Authority Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the communication sent to shareholders on July 29, 2026 relating to Notice of transfer of equity shares of the Company / dividend to Investor Education and Protection Fund. The above information will also be available on the website of the Company at www.jubilantpharmova.com. We request you to take the same on record. Thanking you, Yours faithfully, For Jubilant Pharmova Limited Naresh Kapoor Company Secretary Encl. As above Jubilant Pharmova Limited (CIN: L24116UP1978PLC004624) Regd. Office: Bhartiagram, Gajraula, District Amroha - 244 223 (U.P.) Email: investors@jubl.com Website: www.jubilantpharmova.com Phone: +91-5924-267437 For immediate action Folio No./DP ID-Client Id: Date : Sub: Reminder to claim unpaid/ unclaimed Dividend of Jubilant Pharmova Limited/ Transfer of Equity Shares of Jubilant Pharmova Limited to the Investor Education and Protection Fund Dear Shareholder(s), We wish to inform you that pursuant to the provisions of Section 124(6) of the Companies Act, 2013 (the 'Act') read with the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 (the IEPF Rules ), as amended, al l shares in respect of which dividend has not been paid or claimed for 7 (seven) consecutive years or more are required to be transferred by the Company to the Investor Education and Protection Fund ( IEPF ) on the due date. Kindly note that the Company will not transfer such shares to the IEPF, wherein there is a specific restraining order from any authority or where such shares are pledged or hypothecated under the provisions of the Depositories Act, 1996. Our records show that dividend for the financial year 2018-19 paid by the Company to you has remained unclaimed. Accordingly, the unpaid / unclaimed dividend for the said financial year is due for transfer to IEPF on October 31, 2026. Details of unpaid / unclaimed dividend for the above-referred Folio/ DPID-Client ID for the financial year 2018-19 and subsequent years are given below: Financial Year 2018-19 2019-20 2020-21 2021-22 2022-23 2023-24 2024-25 Dividend Amount (Rs) As dividend for 7 consecutive years has remained unclaimed on these equity shares, the Company is required to transfer ___ Equity Share(s) of the Company held by you in the captioned Folio No./ DP - Client ID to the Demat Account of the IEPF Authority in compliance with the applicable provisions of the IEPF Rules. Details of the shares to be transferred to the IEPF Authority are also available on the website of the Company www.jubilantpharmova.com. Please note that the subsequent corporate benefits accruing on such shares shall also be credited to the IEPF Authority in compliance with the IEPF Rules. In view of the above, we request you to claim the unpaid / unclaimed dividend by making an application to Alankit Assignments Limited (Unit: Jubilant Pharmova Limited), 205-208 Anar kali Complex, Jhandewalan Extension, New Delhi-110055. Your application for claiming the unpaid /unclaimed dividends should reach Alankit Assignments Limited on or before August 31, 2026 to enable us to process your application well before time so that your dividend and Equity Share(s) are not transferred to the IEPF Authority in compliance with the IEPF Rules. Please note that no claim shall lie against the Company in respect of the dividend and Equity Share(s) transferred to the IEPF Authority. However, in terms of Section 124(6) of the Act read with Rule 7 of the IEPF Rules, you may claim the dividend and Equity Share(s) so transferred to the IEPF Authority by making an online application to the IEPF Authority in Form IEPF-5 and by following the procedure prescribed under the IEPF Rules. We request you to treat this matter on priority. Thanking you, Yours faithfully, For Jubilant Pharmova Limited Naresh Kapoor Company Secretary This is computer generated letter and does not require signature. Jubilant Pharmova Limited (CIN: L24116UP1978PLC004624) Regd. Office: Bhartiagram, Gajraula, District Amroha - 244 223 (U.P.) Email: investors@jubl.com Website: www.jubilantpharmova.com Phone: +91-5924-267437 For immediate action Folio No./DP ID-Client Id: Date : Sub: Reminder to claim unpaid/ unclaimed Dividend of Jubilant Pharmova Limited/Transfer of Equity Shares of Jubilant Pharmova Limited to the Investor Education and Protection Fund Dear Shareholder(s), We wish to inform you that pursuant to the provisions of Section 124(6) of the Companies Act, 2013 (the "Act") read with the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 (the "IEPF Rules"), as amended, all shares in respect of which dividend has not been paid or claimed for 7 (seven) consecutive years or more, are required to be transferred by the Company to the Investor Education and Protection Fund ("IEPF") on the due date. Kindly note that the Company will not transfer such shares to the IEPF, wherein there is a specific restraining order from any authority or where such shares are pledged or hypothecated under the provisions of the Depositories Act, 1996. Our records show that you had not surrendered old Rs. 10 denominated share certificates of Ramganga Fertilizers Limited/ Vam Organic Chemicals Limited/ Jubilant Organosys Limited and / or Rs. 5 denominated share certificates of Jubilant Organosys Limited for exchange with new Re. 1 denominated share certificates. Pursuant to the provisions of Clause 5A(II) of the erstwhile Listing Agreement with the stock exchanges, the Company had sent you reminders for taking delivery of the unclaimed shares registered in your name. Since the share certificate(s) were not claimed by you despite reminders, these shares were transferred to Jubilant Pharmova Limited-Unclaimed Suspense Account (Unclaimed Suspense Account) in the year 2012. Presently, share certificate(s) representing ___ Equity Share(s) of Re. 1 each of the Company registered in your name in the captioned folio are lying with us. For claiming new share certificate(s) of Re. 1 each of the Company, we request you to surrender old share certificates of the Company. Dividend for the financial year 2018-19 which remains unpaid is due for transfer to the IEPF on October 31, 2026. Details of unpaid / unclaimed dividends for the above-referred Folio/ DPID-Client ID for the Financial Year 2018-19 and subsequent years are given below: Financial Year 2018-19 2019-20 2020-21 2021-22 2022-23 2023-24 2024-25 Dividend Amount (Rs) As dividend for 7 consecutive years has remained unclaimed on these shares, the Company is required to transfer these ____ Equity Share(s) in the captioned Folio No. /DP ID- Client ID to the Demat Account of the IEPF Authority in compliance with the applicable provisions of the IEPF Rules. Details of the shares to be transferred to the IEPF Authority are also available on the website of the Company www.jubilantpharmova.com. Please note that the subsequent corporate benefits accruing on such shares shall also be credited to the IEPF Authority in compliance with the IEPF Rules. In view of the above, we once again request you to claim the unpaid dividend and unclaimed equity shares by making an application to Alankit Assignments Limited (Unit: Jubilant Pharmova Limited), 205-208, Anar Kali Complex, Jhandewalan Extension, New Delhi - 110055 along with the following documents on or before August 31, 2026 to enable us to process your application well before time so [Showing first 8,000 characters — download PDF for full document]